US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

27.91

+0.36001.31%

Post-market: 27.910.00000.00%16:10 EDT

Volume:1K

Turnover:30.31K

Market Cap:5.58M

PE:- -

High:27.94

Open:27.94

Low:27.88

Close:27.55

52wk High:27.94

52wk Low:22.63

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.20

T/O Rate:0.54%

Dividend:0.41

Dividend Rate:1.48%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating

MT Newswires Live

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Eli Lilly (LLY) On Foundayo Launch And Higher Outlook Faces A Rich Valuation

Simply Wall St.

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

Hims & Hers’ weight-loss plans draw penalties by Visa, Bloomberg reports

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

Roche, Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

Scholar Rock (SRRK) Is Up 8.5% After De-Risking Apitegromab’s Global Filing Pathway - Has The Bull Case Changed?

Simply Wall St.

Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England

THOMSON REUTERS

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS

Hims & Hers (HIMS) Stock Looks Like A Bargain After A 396% Run

Simply Wall St.

Market Chatter: Hims & Hers Health Faces Nearly $75,000 Bill From Card Disputes

MT Newswires Live

Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says

MT Newswires Live

Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/THNR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"THNR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","market":"US","secType":"STK","nameCN":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","latestPrice":27.91,"timestamp":1787688000000,"preClose":27.55,"halted":0,"volume":1086,"hourTrading":{"tag":"盘后","latestPrice":27.91,"preClose":27.91,"latestTime":"16:10 EDT","volume":6,"amount":167.46,"timestamp":1787688604599,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01306715063520869,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Not Yet Opened","change":0.36,"latestTime":"08-25 16:00:00 EDT","open":27.94,"high":27.94,"low":27.875,"amount":30313,"amplitude":0.002359,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":27.55,"sharesOutstanding":170000,"nav":27.49,"aum":5498000,"dividendRate":0.014808,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.91,"preClose":27.91,"latestTime":"16:10 EDT","volume":6,"amount":167.46,"timestamp":1787688604599,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.20135},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.20135,"shares":200000,"dividePrice":0.4133,"high":27.94,"amplitude":0.002359,"preClose":27.55,"low":27.875,"week52Low":22.6289,"pbRate":"--","week52High":27.94,"institutionHeld":0,"latestPrice":27.91,"eps":0,"divideRate":0.014808,"volume":1086,"delay":0,"ttmEps":0,"open":27.94,"prevYearClose":25.22,"prevWeekClose":27.5374,"prevMonthClose":25.3958,"prevQuarterClose":25.6909,"fiveDayClose":26.4611,"twentyDayClose":26.0851,"sixtyDayClose":24.9232},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THNR\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"THNR","amount":0.41317273,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2024-12-30","symbol":"THNR","amount":0.219898,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THNR\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2024-12-31","value":0.219898,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.41317273,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THNR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THNR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662208954","title":"Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208954","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208954?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:16","pubTimestamp":1787591793,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) has an average rating of hold and mean price target of $32.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIYY","HIMS","HEAL","HIMY","HMYY","GLAM","HIMZ","THNR","BK4196","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270747","title":"Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270747?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:31","pubTimestamp":1787589070,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk A/S (NVO) has launched AMAZE 9, a Phase 3 obesity study title...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-amaze-9-oral-obesity-trial-a-new-pill-in-the-weight-loss-race?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-amaze-9-oral-obesity-trial-a-new-pill-in-the-weight-loss-race?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","IE00BKVL7J92.USD","BK4007","NVO","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","NVOC","BK4585","BK4588","NVOX","NVOH","LU1093756168.USD","OZEM","THNR","LU1093756325.SGD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270749","title":"Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270749","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270749?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:30","pubTimestamp":1787589016,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The Phase 1 study, officially titled “A Phase-1, Parallel-Design,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lillys-new-obesity-drug-ly3549492-moves-forward-with-completed-phase-1-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lillys-new-obesity-drug-ly3549492-moves-forward-with-completed-phase-1-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930730.SGD","LU1868836757.USD","FTXH","LLYZ","AGNG","LU2471134952.CNY","LU2491049909.HKD","LU2491050154.USD","LU2750360997.AUD","LU0345770308.USD","LU2361045086.USD","LU2552382215.SGD","LU2108987350.USD","IE00B7KXQ091.USD","IE00B1BXHZ80.USD","LU0234572021.USD","LU0158827781.USD","LU2746668461.USD","LU2023251221.USD","THNR","LU1868837136.USD","LU2552382058.USD","FHLC","BK4581","SGXZ81514606.USD","LU1691799644.USD","LU2237443622.USD","LU0109391861.USD","LU2089283258.USD","LU0354030511.USD","LU0943347566.SGD","BK4585","LU0079474960.USD","BK4588","LU2168564065.EUR","PPH","SG9999001176.SGD","LU0289739699.SGD","LU0354030438.USD","LU1093756168.USD","LU0672654240.SGD","IE00BK4W5L77.USD","LU0094547139.USD","LU0203201768.USD","LU0353189680.USD","LU1069344957.HKD","LU0964807845.USD","LU0466842654.USD","LU1548497426.USD","LU2237443895.HKD","SG9999015945.SGD","LU1057294990.SGD","LU0158827948.USD","LU0683600562.USD","LU2756315318.SGD","LU0058720904.USD","IE0004445239.USD","LU1720051017.SGD","LU2112291526.USD","LU2746668974.SGD","SGXZ99366536.SGD","IE00B4JS1V06.HKD","LU2089984988.USD","SGXZ51526630.SGD","LU2361044865.SGD","IE00BKPKM429.USD","LU0823434740.USD","LU2111349929.HKD","LU1280957306.USD","LU2211815571.USD","LU0133085943.USD","BK4599","LU2552382132.HKD","LU2417539215.USD","LU1551013425.SGD","GDOC","LU0786609619.USD","TMED","IE0004445015.USD","TRUH","IE00BJJMRY28.SGD","SG9999018857.SGD","CURE","SG9999014914.USD","LU2087625088.SGD","LU2237443465.HKD","LU1061106388.HKD","IXJ","LU0417517546.SGD","SG9999015986.USD","LU1917777945.USD","LU2213496289.HKD","IE0001KFT4U8.USD","LU0320765992.SGD","IE00B2B36J28.USD","LU1127390331.HKD","LU2168563687.JPY","OZEM","WDNA","MHIP","LU2461242641.AUD","LU0320765059.SGD","LU0820562030.AUD","IE00B1XK9C88.USD","LLY","BK4534","LU0114720955.EUR","LU2756315664.SGD","SGXZ57979304.SGD","LU2237443549.SGD","SG9999018865.SGD","LU2360106947.USD","SG9999014880.SGD","LU0456855351.SGD","LU0316494557.USD","LU2471134523.USD","LU0708995401.HKD","LU1232071149.USD","SG9999001176.USD","LU0882574139.USD","MEDI","LU0385154629.USD","LU1623119135.USD","SG9999014906.USD","LU2106854487.HKD","SGXZ31699556.SGD","LU0889565916.HKD","LU0820561909.HKD","LU0256863902.USD","LU1814569148.SGD","IE00BFSS7M15.SGD","LU0225283273.USD","LU2168564495.EUR","LU2750360641.GBP","LU0174119429.USD","LU0109394709.USD","LU1064131342.USD","LU1551013342.USD","LU2456880835.USD","LU1804176565.USD","LU1983299246.USD","LU0882574055.USD","LU2265009873.SGD","SG9999013999.USD","LU1023059063.AUD","LU1712237335.SGD","LU1323610961.USD","IE00B4R5TH58.HKD","LU0096364046.USD","LU0823416689.USD","ELIS","LU2236285917.USD","BK4533","LU2324357040.USD","LU2168564149.EUR","LU1145028129.USD","LU1366192091.USD","LU0323591593.USD","MEDX","SG9999017495.SGD","CANC","IHE","IE00BJJMRX11.SGD","IE00BWXC8680.SGD","LU1629891620.HKD","LU1979441026.SGD","IE0002141913.USD","LU1974910355.USD","LU0061475181.USD","RXL","LU2237443978.SGD","LU2237443382.USD","LU1291159041.SGD","IE00BKDWB100.SGD","LU0640476718.USD","LU0122379950.USD","LU1868836914.USD","LU0256863811.USD","LU0238689110.USD","LU2023250330.USD","LLYX","LU0432979614.USD","HRTS","LU0787776722.HKD","LU1868837300.USD","LU2361044949.HKD","IE00B775H168.HKD","LU2028103732.USD","IE00BN29S564.USD","LU2023250504.SGD","LU0006306889.USD","BK4007","GB00BDT5M118.USD","LU0689472784.USD","LU0097036916.USD","LU1989771016.USD","LU2089284900.SGD","LU2471134879.HKD","LU0823434583.USD","LU1720051108.HKD","IE0009355771.USD","LU2264538146.SGD","LU2357305700.SGD","LU0266013472.USD","LU0820561818.USD","LU0198837287.USD","VHT","LU2462157665.USD","ILDR","LU2063271972.USD","IE00BK4W5M84.HKD","LU2491050071.SGD","LU1093756325.SGD","LU0106261372.USD","SG9999015952.SGD","LU2896262040.SGD","IYH","SG9999014898.SGD","LU2168564222.USD","LU2602419157.SGD","LLII","LU2468319806.SGD","LU1868836591.USD","LU0353189763.USD","LU2471134796.USD","LU0210536198.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0471298777.SGD","LU2271345857.HKD","IE0005OL40V9.USD","XLV","LU0471298694.HKD","SG9999015978.USD","LU2237438978.USD","ELIL","LU0345770993.USD","LU1988902786.USD","PJP","IE00BFSS8Q28.SGD","LU2462591350.SGD","LU0203202063.USD","LU1035775433.USD","IE00BJT1NW94.SGD","IE00BJLML261.HKD","JDOC","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270631","title":"Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270631","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270631?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:02","pubTimestamp":1787587320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B dropped 0.5% to DKK299.25 Monday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,710.02.The company closed DKK110.70 below its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 3,241,705, compared to the 50-day average trading volume of 4,317,428.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NVOH","THNR","OZEM","PPH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4599","LU1093756168.USD","LU1093756325.SGD","NVOX","BK4585","BK4007","NVO","NVOC","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208091","title":"Eli Lilly (LLY) On Foundayo Launch And Higher Outlook Faces A Rich Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208091","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208091?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:25","pubTimestamp":1787585159,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) has moved further into obesity and diabetes care with the UK launch of its once daily oral GLP-1 pill Foundayo, orforglipron, shortly after lifting its full year outlook.\nSee our latest analysis for Eli Lilly.\nThe launch of Foundayo comes during a strong run for Eli Lilly’s stock, with a 90 day share price return of 17.91% and a 1 year total shareholder return of 81.69%. This indicates momentum that has built rather than faded over multiple years.\nIf you are interested in how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-on-foundayo-launch-and-higher-outlook-faces-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-on-foundayo-launch-and-higher-outlook-faces-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1804176565.USD","LU0109391861.USD","LU0417517546.SGD","LU2462591350.SGD","SGXZ31699556.SGD","LU0079474960.USD","LU2237438978.USD","LU0096364046.USD","SG9999018865.SGD","LU2456880835.USD","PJP","LU2471134952.CNY","IE0004445239.USD","LU0256863811.USD","LU0432979614.USD","IE00BKPKM429.USD","LU0689472784.USD","LU0094547139.USD","MEDX","SG9999014914.USD","LU2746668461.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU0097036916.USD","LU2361044865.SGD","LU1868837136.USD","LU1061106388.HKD","LU2237443382.USD","FTXH","LU2237443895.HKD","LU0109394709.USD","LU0323591593.USD","LU2360106947.USD","LU0058720904.USD","ELIS","LU2552382058.USD","LU2756315664.SGD","LU2471134879.HKD","IE00B7KXQ091.USD","LU2552382215.SGD","LU1720051108.HKD","LU2468319806.SGD","SG9999015978.USD","LU1868836914.USD","IE00B775H168.HKD","LU1023059063.AUD","LU0708995401.HKD","LU1069344957.HKD","BK4585","LU0266013472.USD","ELIL","LU1280957306.USD","AGNG","LU0683600562.USD","LU2168563687.JPY","SG9999013999.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","LU0061475181.USD","LU0466842654.USD","IE00B4R5TH58.HKD","LU0133085943.USD","LU0158827948.USD","LU0174119429.USD","THNR","LU0225283273.USD","LU0203202063.USD","SG9999017495.SGD","LU1989771016.USD","BK4516","LU2108987350.USD","LU2087625088.SGD","LU1988902786.USD","LU1093756168.USD","IE0004445015.USD","ILDR","LU2023251221.USD","IE0002141913.USD","LU1551013342.USD","VHT","LU2023250504.SGD","SGXZ99366536.SGD","LU0385154629.USD","LU1323610961.USD","BK4534","LU0882574139.USD","LU2111349929.HKD","LU0354030438.USD","LU2324357040.USD","GB00BDT5M118.USD","LU2089984988.USD","SG9999015952.SGD","LU1979441026.SGD","LU1868837300.USD","LU0820562030.AUD","LU1064131342.USD","LU0203201768.USD","LU2237443549.SGD","IE0005OL40V9.USD","LU2491050071.SGD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU0320765059.SGD","LU1127390331.HKD","LU1974910355.USD","LU0964807845.USD","LU1057294990.SGD","LU0114720955.EUR","LU1623119135.USD","CANC","LU0882574055.USD","LU2746668974.SGD","BK4599","LU1629891620.HKD","SG9999014880.SGD","LU2265009873.SGD","LU1712237335.SGD","IE0001KFT4U8.USD","LU2237443622.USD","LU0198837287.USD","IE00BK4W5L77.USD","LU1232071149.USD","LU0256863902.USD","LU1366192091.USD","BK4007","LU0234572021.USD","LU1720051017.SGD","LU0006306889.USD","SG9999014906.USD","LU2089283258.USD","WDNA","LU2271345857.HKD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","LU0640476718.USD","BK4581","LU1691799644.USD","LU2462157665.USD","LU1267930730.SGD","LU1868836591.USD","LU0471298694.HKD","LU1291159041.SGD","LU2750360997.AUD","LU0471298777.SGD","LU2213496289.HKD","LLYZ","LU0106261372.USD","LU1093756325.SGD","LU2089284900.SGD","LU0354030511.USD","LU2756315318.SGD","LU2211815571.USD","IE00BN29S564.USD","LU2028103732.USD","LU2750360641.GBP","LU1983299246.USD","SG9999001176.USD","LLY","LU1814569148.SGD","LU0823434583.USD","LU2237443465.HKD","LU2361044949.HKD","MEDI","LU0158827781.USD","IE00B4JS1V06.HKD","XLV","SG9999001176.SGD","TRUH","LU0889565916.HKD","BK4533","IE00BJJMRY28.SGD","LU2023250330.USD","LU2361045086.USD","SG9999015986.USD","FHLC","IE00BJJMRX11.SGD","LU2357305700.SGD","LU2471134523.USD","LU0353189763.USD","SG9999014898.SGD","LU2063271972.USD","LU0210536198.USD","LU0456855351.SGD","LU0672654240.SGD","OZEM","LU0820561818.USD","IE00B1XK9C88.USD","LU2168564149.EUR","LU2106854487.HKD","LU0238689110.USD","LU2602419157.SGD","LU2896262040.SGD","TMED","LU0345770993.USD","LU0316494557.USD","BK4588","LU2168564495.EUR","LLYX","LU0943347566.SGD","LU1551013425.SGD","PPH","LU2461242641.AUD","RXL","LU2168564065.EUR","SGXZ51526630.SGD","LU0786609619.USD","IE00BJLML261.HKD","IHE","LU2168564222.USD","LLII","LU0823434740.USD","LU2264538146.SGD","LU2491049909.HKD","SG9999018857.SGD","LU0353189680.USD","LU2491050154.USD","LU0823416689.USD","IE0009355771.USD","LU1145028129.USD","IYH","LU1548497426.USD","IE00BJT1NW94.SGD","LU0345770308.USD","JDOC","GDOC","LU2552382132.HKD","IE00BWXC8680.SGD","LU1868836757.USD","HRTS","LU0320765992.SGD","LU0820561909.HKD","LU1917777945.USD","LU0787776722.HKD","LU1035775433.USD","LU0289739699.SGD","IE00BFSS8Q28.SGD","IE00BK4W5M84.HKD","MHIP","LU2112291526.USD","LU0122379950.USD","IE00BKDWB100.SGD","LU2471134796.USD","SGXZ81514606.USD","LU2237443978.SGD","IXJ","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727717","title":"Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727717","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727717?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:18","pubTimestamp":1787584692,"startTime":"0","endTime":"0","summary":"Novo Nordisk ( ($NVO) ) has issued an announcement. On 6 May 2026, Novo Nordisk launched a share repurchase programme under EU Safe Harbour rules a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-details-progress-in-dkk-15-billion-share-buyback-programme-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-details-progress-in-dkk-15-billion-share-buyback-programme-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","NVOH","IE00BKVL7J92.USD","NVO","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","OZEM","BK4585","NVOX","BK4588","PPH","NVOC","BK4007","LU1093756168.USD","LU1093756325.SGD","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272481","title":"Hims & Hers’ weight-loss plans draw penalties by Visa, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661272481?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:30","pubTimestamp":1787581813,"startTime":"0","endTime":"0","summary":"Hims & Hers (HIMS) has been placed in Visa’s (V) Acquirer Monitoring Program after a surge in weight-loss subscription disputes, adding scrutiny to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hims-hers-weight-loss-plans-draw-penalties-by-visa-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hims-hers-weight-loss-plans-draw-penalties-by-visa-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0342679015.USD","LU0823421416.USD","LU2360032135.SGD","LU1267930730.SGD","LU0557290698.USD","LU1037948541.HKD","LU1400636491.USD","HEAL","LU0823417737.USD","LU0154236417.USD","LU2471134952.CNY","LU2750360997.AUD","BK4598","LU2361045086.USD","LU0234572021.USD","IE00B1BXHZ80.USD","LU2746668461.USD","LU0158827781.USD","LU1645745479.HKD","LU1791710400.SGD","LU2023251221.USD","THNR","IE00BQXX3D17.EUR","LU0690374961.EUR","LU1267930573.SGD","LU2023250843.SGD","LU1670627923.USD","BK4581","LU2506952170.USD","LU1935043023.USD","SGXZ81514606.USD","UYG","LU1691799644.USD","LU0109391861.USD","LU0061474960.USD","BK4559","LU0128525929.USD","LU0354030511.USD","LU0251132253.USD","BK4585","LU0079474960.USD","BK4588","LU1400636657.SGD","LU2089283258.USD","LU2125909247.SGD","LU1815333072.USD","LU0354030438.USD","LU0672654240.SGD","LU0353189680.USD","LU1069344957.HKD","LU0109392836.USD","LU2125154935.USD","LU2506952097.USD","LU1823568750.SGD","GB00B4LPDJ14.GBP","LU0158827948.USD","LU0683600562.USD","TFNS","LU0994945656.USD","LU1633808545.USD","GB00B4QBRK32.GBP","IE000SO60NU8.SGD","LU2433249047.HKD","LU1935043536.SGD","LU2746668974.SGD","SGXZ99366536.SGD","SGXZ51526630.SGD","LU2361044865.SGD","LU0823434740.USD","LU2111349929.HKD","LU1280957306.USD","LU0133085943.USD","LU1116320901.HKD","BK4527","BK4106","LU0096362180.USD","LU2097829019.USD","IE00BJTD4N35.SGD","LU0689626769.HKD","LU0426417589.USD","LU1228905037.USD","SG9999000418.SGD","LU0265550946.USD","IXG","LU0124676726.USD","LU0889565833.HKD","IE00B19Z8W00.USD","LU0971096721.USD","LU0289961442.SGD","LU2087625088.SGD","SG9999014914.USD","SG9999018857.SGD","LU0127658192.USD","IE00B19Z8X17.USD","LU0417517546.SGD","HIMS","LU1989772840.SGD","SG9999001424.SGD","IE00BJTD4V19.USD","LU1917777945.USD","HIMY","LU1815336760.USD","LU1934455277.USD","LU2764262908.HKD","LU2461242641.AUD","LU0320765059.SGD","LU0444973449.USD","IE00B1XK9C88.USD","BK4534","LU0868494617.USD","LU2764263039.SGD","LU0823421333.USD","LU1791710582.SGD","IE0000B7K699.USD","LU0170899867.USD","LU1043141396.HKD","LU1935042215.USD","SG9999018865.SGD","SG9999014880.SGD","IE00B19Z9505.USD","LU0316494557.USD","IE00BQXX3C00.GBP","HIMZ","LU0345774391.USD","LU0708995401.HKD","LU1232071149.USD","IE000MB6IJN5.SGD","LU1989772923.USD","LU2471134523.USD","LU0234570918.USD","LU1228905540.USD","LU0187121727.USD","LU1046421795.USD","LU2506951875.HKD","LU1623119135.USD","LU0472753341.HKD","SG9999014906.USD","LU2106854487.HKD","SGXZ31699556.SGD","LU0265550359.USD","LU1934455194.USD","LU1435385759.SGD","IE000F7OJYX1.SGD","LU0256863902.USD","LU1236620750.USD","LU2506951958.HKD","IE00BKVL7J92.USD","LU0426412945.USD","LU0225283273.USD","LU1814569148.SGD","LU2750360641.GBP","LU0174119429.USD","LU1064131342.USD","BK4227","LU1803068979.SGD","LU0861579265.USD","LU1861220207.SGD","LATR","LU1804176565.USD","IE00BQXX3F31.USD","LU1366333091.USD","LU2265009873.SGD","LU2764263203.CNY","LU2720916845.USD","LU1712237335.SGD","LU0345774631.USD","LU0965509283.SGD","V","VFH","LU1121112475.USD","LU0310800379.SGD","BK4533","LU2125909593.SGD","LU0069063385.USD","LU0957791311.USD","BK4196","SG9999017495.SGD","GLAM","LU0444971666.USD","LU0215105999.USD","IE00BWXC8680.SGD","LU0965509101.SGD","LU1069347547.HKD","LU0708994859.HKD","LU1236620834.HKD","LU1935042991.SGD","LU0950375773.USD","LU1934455863.HKD","LU1979441026.SGD","LU0528227936.USD","LU1363072403.SGD","LU1974910355.USD","LU0048584097.USD","HIMC","FNCL","LU0957808578.USD","LU0965508806.USD","LU1037948897.HKD","IE00BKDWB100.SGD","LU0640476718.USD","LU1923622614.USD","HIYY","IPAY","LU0476273544.USD","LU2404859667.USD","LU0256863811.USD","LU0057025933.USD","TRUF","HMYY","LU0787776722.HKD","LU0545562505.USD","LU2361044949.HKD","LU0348723411.USD","IE00BZ1G4Q59.USD","LU2028103732.USD","IE000WAW04H5.SGD","LU1316542783.SGD","LU2023250504.SGD","LU0006306889.USD","LU2089284900.SGD","LU2471134879.HKD","LU0097036916.USD","LU0823417653.USD","LU0823434583.USD","LU2264538146.SGD","LU0289739343.SGD","LU0390134368.USD","LU2404859741.USD","LU2244417387.USD","LU0642271901.SGD","LU0511384066.AUD","LU0690374615.EUR","LU2242649171.HKD","LU1852331112.SGD","LU2326559502.SGD","LU2360107671.USD","LU1429558221.USD","LU0106261372.USD","LU1642822529.SGD","LU0289941410.SGD","LU1035773651.USD","LU1670756490.USD","SG9999014898.SGD","LU1035775433.USD","LU0965509010.AUD","LU2125154778.USD","IE000BZT7R73.USD","LU0353189763.USD","LU1043141123.HKD","LU0056508442.USD","LU2471134796.USD","LU1861217088.USD","XLF","LU2271345857.HKD","LU1670628061.USD","LU1935042488.USD","IYG","LU0175139822.USD","LU1400636574.HKD","FDFF","LU0289960550.SGD","LU2237438978.USD","LU1202635105.USD","LU1988902786.USD","BK4535","LU0868494708.USD","LU0157215616.USD","LU2462591350.SGD","LU0029864427.USD","LU0942090050.USD","LU1116320737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271595","title":"Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271595","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271595?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:12","pubTimestamp":1787577120,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals has earned a third $10 million milestone payment from Novo Nordisk for hitting a key milestone in the clinical development program for its obesity drug.The biopharmaceutical company on Monday said that it has achieved a patient dosing milestone in the continuing phase 1 program for LX9851, a treatment being developed for obesity and associated metabolic disorders.Lexicon and Novo Nordisk signed an exclusive worldwide license agreement for LX9851 last year, under which Novo Nordisk is able to develop, manufacture and commercialize the drug for all indications.So far, Lexicon has earned $75 million of the $1 billion in potential upfront, development, regulatory and commercial milestone payments available under its Novo Nordisk collaboration. Lexicon is also entitled to receive tiered royalties on future LX9851 sales.The development program for LX9851 was kicked off by Novo Nordisk in March to investigate the safety, tolerability, pharmacokinetics and pharmacodynam","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LXRX","LU1093756168.USD","THNR","BK4007","NVOC","BK4532","BK4139","NVOX","NVO","NVOH","OZEM","LU0154236417.USD","PPH","LU1093756325.SGD","BK4599","IE00BKVL7J92.USD","BK4588","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279033","title":"Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279033?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:45","pubTimestamp":1787575521,"startTime":"0","endTime":"0","summary":"Lexicon (LXRX) announced that it has earned a third $10M milestone payment in 2026 from Novo Nordisk (NVO) following the achievement of a patient d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexicon-earns-third-10m-milestone-payment-from-novo-nordisk-for-lx9851-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexicon-earns-third-10m-milestone-payment-from-novo-nordisk-for-lx9851-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1093756168.USD","BK4585","IE00BKVL7J92.USD","LXRX","NVOX","BK4599","NVOH","LU0154236417.USD","BK4139","BK4007","THNR","BK4588","OZEM","NVOC","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661427527","title":"Roche, Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2661427527","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661427527?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:51","pubTimestamp":1787572278,"startTime":"0","endTime":"0","summary":"Roche, Eli Lilly's Alzheimer's blood test gets FDA clearanceAug 24 (Reuters)-The U.S. Food and Drug Administration has cleared RocheROPC.Sand partner Eli Lilly'sLLY.Nblood test to help identify signs ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L0T4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069344957.HKD","LU2237443895.HKD","LU0006306889.USD","LU2023250504.SGD","LU2456880835.USD","FHLC","LU0466842654.USD","LLYX","BK4516","MHIP","SG9999014898.SGD","IE00BJJMRZ35.SGD","LU2089283258.USD","LU1551013342.USD","LU1988902786.USD","LU2746668461.USD","LU2236285917.USD","LU0234572021.USD","LU0114720955.EUR","LU1093756325.SGD","SGXZ99366536.SGD","IE00BJJMRX11.SGD","LU2746668974.SGD","LU2896262040.SGD","SG9999015978.USD","03165","TRUH","IE0004445015.USD","LU0417517546.SGD","LU0109391861.USD","LU0820562030.AUD","IE0001KFT4U8.USD","LU0354030438.USD","LU0943347566.SGD","LU0225283273.USD","LU2237443465.HKD","LU2471134523.USD","TMED","LU2471134879.HKD","LU0964807845.USD","IE00BJLML261.HKD","LU2237443978.SGD","LU0354030511.USD","LU2471134796.USD","LU0823434583.USD","LU0256863902.USD","SG9999014914.USD","LU0456855351.SGD","CANC","SG9999013999.USD","LU2237443549.SGD","LU0106261372.USD","IE00B1XK9C88.USD","LU2462157665.USD","RHHBY","LU2168564495.EUR","LU2462591350.SGD","IE00BN29S564.USD","SG9999001176.SGD","SG9999014906.USD","LLY","LU0640476718.USD","IE00BKDWB100.SGD","LU0353189680.USD","LU1267930730.SGD","SG9999017495.SGD","BK4007","LU2357305700.SGD","IE00B7KXQ091.USD","IE00BK4W5L77.USD","LU1291159041.SGD","IXJ","LU2106854487.HKD","LU1868837136.USD","IE00BFTCPJ56.SGD","LU2552382132.HKD","LU1712237335.SGD","LU0823434740.USD","LU1804176565.USD","LU0133085943.USD","GDOC","BK4533","LU0198837287.USD","LU1127390331.HKD","LU1145028129.USD","SG9999001176.USD","LU0109394709.USD","SG9999015986.USD","FTXH","LU2237443382.USD","SG9999014880.SGD","IE00B4JS1V06.HKD","LU0316494557.USD","LU0203201768.USD","IE00B2B36J28.USD","LU0210536198.USD","LU0471298694.HKD","LU2089984988.USD","LU1979441026.SGD","IYH","LU0820561818.USD","LU2023251221.USD","LU2491050154.USD","JDOC","PJP","LU1548497426.USD","LU1323610961.USD","LU0323591593.USD","LU1061106388.HKD","LU1629891620.HKD","IE00BJT1NW94.SGD","RXL","SG9999018857.SGD","LU0094547139.USD","LU1035775433.USD","LU2552382215.SGD","LU1720051108.HKD","LU0097036916.USD","IE00BWXC8680.SGD","LU0289739699.SGD","LU1720051017.SGD","LU0096364046.USD","BK4585","LU2271345857.HKD","IE0005OL40V9.USD","BK4581","LU2324357040.USD","LU1814569148.SGD","LU2023250330.USD","LU0122379950.USD","AGNG","MEDI","PPH","LU2471134952.CNY","LU0058720904.USD","HRTS","LLYZ","LU0689472784.USD","LU0079474960.USD","LU2750360641.GBP","LU2417539215.USD","LU2237443622.USD","IE0004445239.USD","LU0266013472.USD","LU1868836591.USD","IE00B1BXHZ80.USD","ELIS","LU1868837300.USD","LU0256863811.USD","LU1093756168.USD","LU2468319806.SGD","LU2168564222.USD","IHE","LU1623119135.USD","LU0820561909.HKD","LU2237438978.USD","LU2211815571.USD","LU0708995401.HKD","LU2168564149.EUR","LU2168563687.JPY","VHT","BK4534","LU1868836757.USD","LU0345770308.USD","IE00BJJMRY28.SGD","LU0787776722.HKD","MEDX","THNR","LU2264538146.SGD","LU0238689110.USD","LU0385154629.USD","IE00BK4W5M84.HKD","IE00BFSS7M15.SGD","CURE","WDNA","LU0174119429.USD","LU1064131342.USD","LU2108987350.USD","ELIL","LU0345770993.USD","LU2361044949.HKD","LU2361045086.USD","LU2461242641.AUD","LU2360106947.USD","XLV","LU2552382058.USD","LU2361044865.SGD","LU0889565916.HKD","LU0432979614.USD","LU2491050071.SGD","LU2602419157.SGD","SGXZ51526630.SGD","LU1366192091.USD","IE00B775H168.HKD","GB00BDT5M118.USD","LU0320765992.SGD","IE0009355771.USD","IE00BKPKM429.USD","LU0203202063.USD","LU1023059063.AUD","LU2087625088.SGD","LU2028103732.USD","LU0158827781.USD","LU0882574139.USD","LU0353189763.USD","IE0002141913.USD","BK4588","LLII","LU0471298777.SGD","LU2112291526.USD","LU1974910355.USD","LU0683600562.USD","LU2756315664.SGD","LU2213496289.HKD","LU0061475181.USD","LU1989771016.USD","LU0823416689.USD","IE00B4R5TH58.HKD","SG9999018865.SGD","LU1868836914.USD","ILDR","LU1691799644.USD","LU1983299246.USD","SGXZ81514606.USD","LU2265009873.SGD","BK4599","LU1280957306.USD","LU2063271972.USD","LU2168564065.EUR","LU2491049909.HKD","SG9999015952.SGD","SGXZ31699556.SGD","SGXZ57979304.SGD","LU1232071149.USD","LU0786609619.USD","LU0320765059.SGD","LU0672654240.SGD","LU2750360997.AUD","LU2111349929.HKD","LU0158827948.USD","LU0882574055.USD","IE00BFSS8Q28.SGD","LU1917777945.USD","LU2089284900.SGD","LU2756315318.SGD","OZEM","LU1057294990.SGD","LU1551013425.SGD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224498","title":"Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661224498?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:45","pubTimestamp":1787561121,"startTime":"0","endTime":"0","summary":"Barclays analyst Emily Field maintained a Buy rating on Eli Lilly & Co today and set a price target of $1,400.00. Field covers the Healthcare secto...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-eli-lilly-co-lly-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-eli-lilly-co-lly-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRY28.SGD","SG9999015945.SGD","FTXH","LU0316494557.USD","LU2471134952.CNY","LU1868836591.USD","SG9999014906.USD","LU0943347566.SGD","LU0689472784.USD","LU1069344957.HKD","LU2089283258.USD","LU1551013342.USD","LU0823434740.USD","LU2168564222.USD","LU0061475181.USD","IE0002141913.USD","IXJ","RXL","VHT","XLV","IE00BKPKM429.USD","LU2361044865.SGD","LU1035775433.USD","LU1145028129.USD","LU0320765059.SGD","FHLC","AGNG","LU2237443465.HKD","IE0004445239.USD","LU2750360641.GBP","SG9999017495.SGD","LU2552382058.USD","LU0787776722.HKD","LU1629891620.HKD","LU0114720955.EUR","LU0323591593.USD","LU2552382132.HKD","LU2471134523.USD","LU2023250330.USD","LU2237443549.SGD","LU2112291526.USD","LU0106261372.USD","LU0354030511.USD","BK4599","LU2361044949.HKD","LU0006306889.USD","LU0417517546.SGD","IYH","LLYX","LU0820562030.AUD","LU0354030438.USD","LU2023250504.SGD","LU1061106388.HKD","LU1323610961.USD","IE00B4JS1V06.HKD","LU0683600562.USD","LU2023251221.USD","PPH","SGXZ81514606.USD","IE00BN29S564.USD","LU0109394709.USD","LU0122379950.USD","IE00B7KXQ091.USD","LU1366192091.USD","LU2237443622.USD","LU2324357040.USD","LU1804176565.USD","GDOC","LU0079474960.USD","LU2602419157.SGD","LU0889565916.HKD","CANC","LU0820561909.HKD","LU2750360997.AUD","LU2417539215.USD","IE00BJT1NW94.SGD","SG9999001176.USD","LU0203202063.USD","LU0198837287.USD","LU0456855351.SGD","LU2360106947.USD","LU2236285917.USD","LU0174119429.USD","LU1093756325.SGD","THNR","LU2264538146.SGD","LU1232071149.USD","SG9999014898.SGD","LU2491050071.SGD","IE00BFTCPJ56.SGD","HRTS","LU2087625088.SGD","LU0203201768.USD","SGXZ57979304.SGD","LU0345770308.USD","LU1623119135.USD","LU2237438978.USD","IE00B2B36J28.USD","IE00BWXC8680.SGD","LU2462157665.USD","LU2896262040.SGD","LU0238689110.USD","OZEM","LU2456880835.USD","LU0097036916.USD","LU0786609619.USD","LU0432979614.USD","LU1551013425.SGD","LU0058720904.USD","TMED","IE0004445015.USD","LU0234572021.USD","LU0096364046.USD","BK4516","LU2106854487.HKD","SG9999015952.SGD","LU0385154629.USD","LU0471298694.HKD","SGXZ51526630.SGD","LU0158827948.USD","LU0820561818.USD","LU2089284900.SGD","MEDX","LU0289739699.SGD","TRUH","LU1868836914.USD","LU1712237335.SGD","LU1291159041.SGD","LU1720051108.HKD","LU0109391861.USD","LU2471134879.HKD","LU0353189680.USD","SG9999001176.SGD","LU2168564065.EUR","LU1093756168.USD","LU2108987350.USD","LU2237443382.USD","LU1720051017.SGD","LU2357305700.SGD","LU2461242641.AUD","LU0964807845.USD","IE00BJLML261.HKD","IE0001KFT4U8.USD","LU1988902786.USD","LU2168564495.EUR","LU2552382215.SGD","LU2361045086.USD","LU0823434583.USD","LU1868837136.USD","SG9999018865.SGD","ILDR","LU0708995401.HKD","BK4533","LU1983299246.USD","ELIS","BK4581","LLY","LU2213496289.HKD","SG9999014914.USD","LU0640476718.USD","LU0882574139.USD","IE0009355771.USD","LU0466842654.USD","LU1057294990.SGD","LU2746668974.SGD","LU0266013472.USD","LU2756315664.SGD","SGXZ31699556.SGD","IE00BFSS8Q28.SGD","IE00BKDWB100.SGD","IE00B4R5TH58.HKD","LU1064131342.USD","LU1023059063.AUD","LU2089984988.USD","LLII","MHIP","LU2211815571.USD","SG9999014880.SGD","LU2168564149.EUR","LU0094547139.USD","LU0256863811.USD","LU0256863902.USD","LU0133085943.USD","IE00BK4W5M84.HKD","CURE","LU0320765992.SGD","IE00BJJMRX11.SGD","LU0823416689.USD","JDOC","LU2468319806.SGD","LU2063271972.USD","LU1974910355.USD","IHE","SG9999013999.USD","LU2491049909.HKD","LU1868836757.USD","LU0672654240.SGD","LU1691799644.USD","LU0353189763.USD","LU1989771016.USD","IE00B775H168.HKD","LU2168563687.JPY","LU1917777945.USD","SG9999018857.SGD","LU0882574055.USD","IE00BFSS7M15.SGD","LU1267930730.SGD","LU2462591350.SGD","MEDI","IE00B1XK9C88.USD","BK4007","BK4534","BK4585","IE00B1BXHZ80.USD","LU1280957306.USD","ELIL","LU1548497426.USD","LU1868837300.USD","LU2237443895.HKD","LU2111349929.HKD","LU0210536198.USD","WDNA","LU2237443978.SGD","LU2756315318.SGD","LU2746668461.USD","BK4588","LU0345770993.USD","LU0471298777.SGD","SG9999015986.USD","LU2491050154.USD","LU0158827781.USD","LLYZ","PJP","LU1814569148.SGD","IE00BK4W5L77.USD","GB00BDT5M118.USD","SGXZ99366536.SGD","LU2471134796.USD","LU2028103732.USD","SG9999015978.USD","IE0005OL40V9.USD","IE00BJJMRZ35.SGD","LU1127390331.HKD","LU2265009873.SGD","LU0225283273.USD","LU1979441026.SGD","LU2271345857.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222175","title":"Scholar Rock (SRRK) Is Up 8.5% After De-Risking Apitegromab’s Global Filing Pathway - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222175","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222175?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:20","pubTimestamp":1787559646,"startTime":"0","endTime":"0","summary":"Earlier this week, Scholar Rock announced it had removed Catalent Indiana from all commercial fill-finish roles in apitegromab’s U.S. BLA for spinal muscular atrophy, withdrawn and planned to resubmit its European filing with an alternate facility, and secured PMDA alignment to file a Japanese application without new local trials.\nThis set of regulatory and manufacturing moves materially reduces operational risk around apitegromab’s global rollout by shifting to a compliant U.S. facility...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-srrk-is-up-85-after-de-risking-apitegromabs-glo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-srrk-is-up-85-after-de-risking-apitegromabs-glo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IBRN","AIPO","SRRK","THNR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661924956","title":"Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England","url":"https://stock-news.laohu8.com/highlight/detail?id=2661924956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661924956?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:01","pubTimestamp":1787526060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nP8N3WW077:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU2491050154.USD","LU2063271972.USD","LU0109391861.USD","IHE","LU2087625088.SGD","LU1814569148.SGD","LLYX","LU2746668974.SGD","LU1291159041.SGD","LU1093756168.USD","IE0002141913.USD","FHLC","LU1720051108.HKD","LU0094547139.USD","LU1720051017.SGD","SG9999014898.SGD","LU2168564065.EUR","LU1023059063.AUD","LU0640476718.USD","LU0417517546.SGD","LU2211815571.USD","LU2417539215.USD","LU1232071149.USD","LU2324357040.USD","BK4516","LU0432979614.USD","LU0823434740.USD","LU2089283258.USD","SGXZ51526630.SGD","LU1691799644.USD","LU0820561909.HKD","LU0256863811.USD","IE00BN29S564.USD","LU0345770308.USD","LU1057294990.SGD","LU2471134796.USD","IE00BK4W5M84.HKD","LU0256863902.USD","LU2471134879.HKD","LU1145028129.USD","LU1548497426.USD","IYH","LU1868837300.USD","LU1988902786.USD","LU0882574139.USD","LU0345770993.USD","BK4534","PPH","VHT","LU1623119135.USD","LU1974910355.USD","LU2089284900.SGD","LU0234572021.USD","LU0210536198.USD","BK4533","LU0787776722.HKD","LU1983299246.USD","SGXZ31699556.SGD","MEDI","IE00BJJMRX11.SGD","IE00BJT1NW94.SGD","LU0266013472.USD","LU0096364046.USD","LU2237443382.USD","LU1868836591.USD","LU2471134523.USD","IE00BFSS7M15.SGD","LU1323610961.USD","LU1629891620.HKD","LU0943347566.SGD","LLYZ","LU0061475181.USD","LU2461242641.AUD","SGXZ99366536.SGD","LU2462591350.SGD","LU2265009873.SGD","THNR","SG9999015952.SGD","LU0122379950.USD","LU2756315664.SGD","IE00BJJMRY28.SGD","LU2023251221.USD","LU2236285917.USD","LU1712237335.SGD","LU0354030511.USD","IE00B2B36J28.USD","LU0353189680.USD","LU0823434583.USD","LU1868837136.USD","LU2023250330.USD","LU0225283273.USD","LU2237443465.HKD","LU2552382058.USD","SG9999013999.USD","LU1069344957.HKD","LU0320765059.SGD","LU2491050071.SGD","HRTS","IE00BWXC8680.SGD","LU0203201768.USD","LU1979441026.SGD","IXJ","LU0471298777.SGD","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU1127390331.HKD","LU2361045086.USD","LU2462157665.USD","LU0203202063.USD","LU2237443978.SGD","LU2552382215.SGD","LU1093756325.SGD","LU2360106947.USD","LU0174119429.USD","BK4599","IE0001KFT4U8.USD","LU0672654240.SGD","LU2237443549.SGD","LU0079474960.USD","LU1267930730.SGD","SG9999014880.SGD","LU0058720904.USD","MHIP","AGNG","IE0004445239.USD","IE00BFSS8Q28.SGD","LU0683600562.USD","LU2168563687.JPY","SG9999015978.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","SG9999001176.SGD","GB00BDT5M118.USD","XLV","SGXZ81514606.USD","LU0354030438.USD","IE00BJLML261.HKD","LU2552382132.HKD","BK4007","LLII","WDNA","IE00BJJMRZ35.SGD","LU0158827781.USD","SG9999015945.SGD","LU0689472784.USD","ELIS","LU0198837287.USD","LU0289739699.SGD","LU0456855351.SGD","IE00B1BXHZ80.USD","TMED","LU2602419157.SGD","LLY","LU0882574055.USD","LU2750360997.AUD","IE00BKPKM429.USD","CURE","LU2106854487.HKD","LU2168564149.EUR","ELIL","LU0471298694.HKD","LU2264538146.SGD","IE0005OL40V9.USD","LU2237443895.HKD","LU0106261372.USD","IE00B4JS1V06.HKD","LU1868836914.USD","IE0004445015.USD","IE00B7KXQ091.USD","LU1280957306.USD","LU1061106388.HKD","LU2357305700.SGD","LU2168564495.EUR","MEDX","IE00B775H168.HKD","PJP","ILDR","IE00B1XK9C88.USD","LU2168564222.USD","SG9999018857.SGD","LU2271345857.HKD","LU0353189763.USD","LU0385154629.USD","LU1035775433.USD","LU1868836757.USD","LU2896262040.SGD","LU0323591593.USD","JDOC","LU1366192091.USD","LU0964807845.USD","SG9999014914.USD","LU0820561818.USD","SG9999018865.SGD","LU2089984988.USD","LU2237443622.USD","LU0316494557.USD","IE00BKDWB100.SGD","LU0238689110.USD","LU0320765992.SGD","LU2491049909.HKD","LU0466842654.USD","IE00BK4W5L77.USD","LU0820562030.AUD","LU0786609619.USD","LU0109394709.USD","LU0006306889.USD","LU2028103732.USD","LU2746668461.USD","LU2468319806.SGD","LU0823416689.USD","LU0708995401.HKD","LU2750360641.GBP","LU0158827948.USD","LU2471134952.CNY","RXL","FTXH","LU2108987350.USD","SG9999015986.USD","LU2756315318.SGD","CANC","LU2237438978.USD","LU2111349929.HKD","LU2023250504.SGD","LU0133085943.USD","SG9999001176.USD","OZEM","LU1551013425.SGD","LU1917777945.USD","LU2361044865.SGD","SG9999014906.USD","LU2361044949.HKD","GDOC","LU1064131342.USD","LU1804176565.USD","LU2456880835.USD","TRUH","LU2213496289.HKD","SG9999017495.SGD","LU1551013342.USD","LU1989771016.USD","LU2112291526.USD","IE0009355771.USD","BK4581","BK4588","LU0097036916.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661495982","title":"Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK","url":"https://stock-news.laohu8.com/highlight/detail?id=2661495982","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661495982?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:01","pubTimestamp":1787526060,"startTime":"0","endTime":"0","summary":"Eli Lilly launches oral weight-loss pill Foundayo in UKAug 24 (Reuters)-Eli LillyLLY.Nsaid on Monday ithaslaunched its oral pill, Foundayo, in the UK for weight management and type 2 diabetes, makingi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nL6N44I0QH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","LU2750360997.AUD","LU1551013342.USD","LU2111349929.HKD","LU2756315664.SGD","LU1145028129.USD","LU2552382215.SGD","LU1720051017.SGD","ELIS","LU2168564495.EUR","BK4599","LU2236285917.USD","LU0133085943.USD","LU0006306889.USD","LU2168563687.JPY","LU0787776722.HKD","LU2471134952.CNY","LU2237443978.SGD","SGXZ57979304.SGD","SGXZ81514606.USD","FHLC","LU0353189680.USD","LU1366192091.USD","LU0882574055.USD","LLII","LU0345770993.USD","LU2271345857.HKD","LU2746668461.USD","LU2361045086.USD","IE00BJJMRX11.SGD","IE00BWXC8680.SGD","LU0210536198.USD","LU1267930730.SGD","LU2746668974.SGD","LU0058720904.USD","LU0079474960.USD","LU0234572021.USD","LU1868836757.USD","IE00B775H168.HKD","LU1280957306.USD","LU2213496289.HKD","LU2324357040.USD","IE0005OL40V9.USD","IE0004445239.USD","RXL","IE00BFTCPJ56.SGD","LU1232071149.USD","SG9999018857.SGD","TRUH","LU2237443622.USD","LU0353189763.USD","LU2491049909.HKD","BK4533","LU1057294990.SGD","LU0256863811.USD","SG9999018865.SGD","LU2023250330.USD","LU2237443465.HKD","IE00BJJMRZ35.SGD","SGXZ51526630.SGD","LU2168564222.USD","LU2028103732.USD","LU2112291526.USD","ILDR","LU0640476718.USD","AGNG","LU1093756168.USD","OZEM","IE00B4JS1V06.HKD","LU0354030438.USD","LU2237443382.USD","LLY","IE00B1BXHZ80.USD","XLV","LU0323591593.USD","LU0114720955.EUR","FTXH","LU0061475181.USD","LU0316494557.USD","LU0820561909.HKD","LU0256863902.USD","LU1974910355.USD","LU1988902786.USD","LU2023251221.USD","LU0096364046.USD","IXJ","LU2168564065.EUR","LU2089284900.SGD","LU0385154629.USD","CURE","LU1127390331.HKD","BK4581","MHIP","SG9999017495.SGD","LU1061106388.HKD","BK4007","GB00BDT5M118.USD","LU1712237335.SGD","SG9999014898.SGD","CANC","BK4534","IE00BFSS7M15.SGD","LU2471134523.USD","PPH","LU1323610961.USD","HRTS","LU0225283273.USD","BK4516","LU0889565916.HKD","LU2264538146.SGD","LU0158827781.USD","ELIL","SG9999014914.USD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2361044865.SGD","IYH","BK4588","LU2552382058.USD","LU0345770308.USD","IE00B7KXQ091.USD","GDOC","LU0198837287.USD","LU1629891620.HKD","LU1917777945.USD","IE00BKPKM429.USD","TMED","LU0203202063.USD","LU0964807845.USD","LU2265009873.SGD","LU2168564149.EUR","LU2237443895.HKD","LU1868836591.USD","SG9999015978.USD","MEDX","IE00BJJMRY28.SGD","LU1093756325.SGD","SG9999014880.SGD","LU2211815571.USD","LU2602419157.SGD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","SG9999015952.SGD","LU0471298694.HKD","LU0820562030.AUD","LU2108987350.USD","LU0820561818.USD","LU2357305700.SGD","LU1064131342.USD","IE0009355771.USD","LU0882574139.USD","LU0094547139.USD","LU0823434740.USD","LU1868837136.USD","LU0708995401.HKD","LU2087625088.SGD","LU2756315318.SGD","LU0471298777.SGD","LU0456855351.SGD","SG9999001176.SGD","SG9999013999.USD","LU1814569148.SGD","LU2023250504.SGD","JDOC","LU1720051108.HKD","LU0158827948.USD","SG9999001176.USD","LU1291159041.SGD","LU1069344957.HKD","LU0109394709.USD","IE00BK4W5L77.USD","LU1983299246.USD","LU0786609619.USD","LU2462157665.USD","LU0289739699.SGD","LU0417517546.SGD","SGXZ99366536.SGD","LLYZ","LU0109391861.USD","LU0683600562.USD","BK4585","PJP","LU2237438978.USD","IE0004445015.USD","LU0174119429.USD","LU0672654240.SGD","LU0320765059.SGD","LU1548497426.USD","LU0266013472.USD","LU2552382132.HKD","SG9999014906.USD","LU0823416689.USD","LU0689472784.USD","LU2461242641.AUD","IE00BJLML261.HKD","LU0823434583.USD","LU2063271972.USD","LU2106854487.HKD","IE00BK4W5M84.HKD","THNR","LU2237443549.SGD","LU2471134879.HKD","LU1691799644.USD","LU0354030511.USD","LU1035775433.USD","IHE","LU2361044949.HKD","LU0943347566.SGD","SG9999015986.USD","LU2468319806.SGD","LU0122379950.USD","LU1804176565.USD","LU2471134796.USD","LU0203201768.USD","LU1979441026.SGD","LU2462591350.SGD","LU2417539215.USD","LU0320765992.SGD","LU0238689110.USD","LU2089984988.USD","WDNA","IE00BN29S564.USD","SG9999015945.SGD","LU1551013425.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2456880835.USD","IE00BKDWB100.SGD","LLYX","LU2896262040.SGD","LU1868837300.USD","LU2089283258.USD","MEDI","VHT","LU1623119135.USD","LU0106261372.USD","LU0466842654.USD","LU0432979614.USD","LU2750360641.GBP","IE00B1XK9C88.USD","LU2491050071.SGD","LU1989771016.USD","LU2360106947.USD","IE0002141913.USD","LU2491050154.USD","SGXZ31699556.SGD","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661249561","title":"Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription","url":"https://stock-news.laohu8.com/highlight/detail?id=2661249561","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661249561?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:01","pubTimestamp":1787526060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nP8N3WW077:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1804176565.USD","LU0109391861.USD","LU0417517546.SGD","LU2462591350.SGD","SGXZ31699556.SGD","LU0079474960.USD","LU2237438978.USD","LU0096364046.USD","SG9999018865.SGD","LU2456880835.USD","PJP","LU2471134952.CNY","IE0004445239.USD","LU0256863811.USD","LU0432979614.USD","IE00BKPKM429.USD","LU0689472784.USD","LU0094547139.USD","MEDX","SG9999014914.USD","LU2746668461.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU0097036916.USD","LU2361044865.SGD","LU1868837136.USD","LU1061106388.HKD","LU2237443382.USD","FTXH","LU2237443895.HKD","LU0109394709.USD","LU0323591593.USD","LU2360106947.USD","LU0058720904.USD","ELIS","LU2552382058.USD","LU2756315664.SGD","LU2471134879.HKD","IE00B7KXQ091.USD","LU2552382215.SGD","LU1720051108.HKD","LU2468319806.SGD","SG9999015978.USD","LU1868836914.USD","IE00B775H168.HKD","LU1023059063.AUD","LU0708995401.HKD","LU1069344957.HKD","BK4585","LU0266013472.USD","ELIL","LU1280957306.USD","AGNG","LU0683600562.USD","LU2168563687.JPY","SG9999013999.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","LU0061475181.USD","LU0466842654.USD","IE00B4R5TH58.HKD","LU0133085943.USD","LU0158827948.USD","LU0174119429.USD","THNR","LU0225283273.USD","LU0203202063.USD","SG9999017495.SGD","LU1989771016.USD","BK4516","LU2108987350.USD","LU2087625088.SGD","LU1988902786.USD","LU1093756168.USD","IE0004445015.USD","ILDR","LU2023251221.USD","IE0002141913.USD","LU1551013342.USD","VHT","LU2023250504.SGD","SGXZ99366536.SGD","LU0385154629.USD","LU1323610961.USD","BK4534","LU0882574139.USD","LU2111349929.HKD","LU0354030438.USD","LU2324357040.USD","GB00BDT5M118.USD","LU2089984988.USD","SG9999015952.SGD","LU1979441026.SGD","LU1868837300.USD","LU0820562030.AUD","LU1064131342.USD","LU0203201768.USD","LU2237443549.SGD","IE0005OL40V9.USD","LU2491050071.SGD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU0320765059.SGD","LU1127390331.HKD","LU1974910355.USD","LU0964807845.USD","LU1057294990.SGD","LU0114720955.EUR","LU1623119135.USD","CANC","LU0882574055.USD","LU2746668974.SGD","BK4599","LU1629891620.HKD","SG9999014880.SGD","LU2265009873.SGD","LU1712237335.SGD","IE0001KFT4U8.USD","LU2237443622.USD","LU0198837287.USD","IE00BK4W5L77.USD","LU1232071149.USD","LU0256863902.USD","LU1366192091.USD","BK4007","LU0234572021.USD","LU1720051017.SGD","LU0006306889.USD","SG9999014906.USD","LU2089283258.USD","WDNA","LU2271345857.HKD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","LU0640476718.USD","BK4581","LU1691799644.USD","LU2462157665.USD","LU1267930730.SGD","LU1868836591.USD","LU0471298694.HKD","LU1291159041.SGD","LU2750360997.AUD","LU0471298777.SGD","LU2213496289.HKD","LLYZ","LU0106261372.USD","LU1093756325.SGD","LU2089284900.SGD","LU0354030511.USD","LU2756315318.SGD","LU2211815571.USD","IE00BN29S564.USD","LU2028103732.USD","LU2750360641.GBP","LU1983299246.USD","SG9999001176.USD","LLY","LU1814569148.SGD","LU0823434583.USD","LU2237443465.HKD","LU2361044949.HKD","MEDI","LU0158827781.USD","IE00B4JS1V06.HKD","XLV","SG9999001176.SGD","TRUH","LU0889565916.HKD","BK4533","IE00BJJMRY28.SGD","LU2023250330.USD","LU2361045086.USD","SG9999015986.USD","FHLC","IE00BJJMRX11.SGD","LU2357305700.SGD","LU2471134523.USD","LU0353189763.USD","SG9999014898.SGD","LU2063271972.USD","LU0210536198.USD","LU0456855351.SGD","LU0672654240.SGD","OZEM","LU0820561818.USD","IE00B1XK9C88.USD","LU2168564149.EUR","LU2106854487.HKD","LU0238689110.USD","LU2602419157.SGD","LU2896262040.SGD","TMED","LU0345770993.USD","LU0316494557.USD","BK4588","LU2168564495.EUR","LLYX","LU0943347566.SGD","LU1551013425.SGD","PPH","LU2461242641.AUD","RXL","LU2168564065.EUR","SGXZ51526630.SGD","LU0786609619.USD","IE00BJLML261.HKD","IHE","LU2168564222.USD","LLII","LU0823434740.USD","LU2264538146.SGD","LU2491049909.HKD","SG9999018857.SGD","LU0353189680.USD","LU2491050154.USD","LU0823416689.USD","IE0009355771.USD","LU1145028129.USD","IYH","LU1548497426.USD","IE00BJT1NW94.SGD","LU0345770308.USD","JDOC","GDOC","LU2552382132.HKD","IE00BWXC8680.SGD","LU1868836757.USD","HRTS","LU0320765992.SGD","LU0820561909.HKD","LU1917777945.USD","LU0787776722.HKD","LU1035775433.USD","LU0289739699.SGD","IE00BFSS8Q28.SGD","IE00BK4W5M84.HKD","MHIP","LU2112291526.USD","LU0122379950.USD","IE00BKDWB100.SGD","LU2471134796.USD","SGXZ81514606.USD","LU2237443978.SGD","IXJ","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661249558","title":"Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120","url":"https://stock-news.laohu8.com/highlight/detail?id=2661249558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661249558?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:01","pubTimestamp":1787526060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nP8N3WW077:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","LU0203201768.USD","LU2491049909.HKD","LLY","LU0689472784.USD","LU1548497426.USD","LU0109391861.USD","LU2168564149.EUR","SG9999015978.USD","IE00BFSS8Q28.SGD","ILDR","LU2357305700.SGD","LU2756315318.SGD","LU0786609619.USD","IE00BJJMRX11.SGD","TMED","LU2324357040.USD","BK4516","LU1366192091.USD","LU1989771016.USD","LU2089283258.USD","LU0889565916.HKD","IXJ","LU0353189763.USD","LU1720051017.SGD","LU2491050154.USD","LU2746668974.SGD","LU0708995401.HKD","LU0096364046.USD","LU0210536198.USD","LU2237438978.USD","GDOC","LU2237443978.SGD","CANC","IE00B2B36J28.USD","LU2552382132.HKD","LU2552382215.SGD","LU2361044949.HKD","LU2265009873.SGD","LU2756315664.SGD","LU0256863902.USD","LU2417539215.USD","LU0203202063.USD","HRTS","SG9999018857.SGD","IE00BJJMRZ35.SGD","IE00BK4W5L77.USD","LU0882574139.USD","SGXZ51526630.SGD","LU0079474960.USD","LU2237443549.SGD","LU2471134879.HKD","LU0882574055.USD","VHT","LU0345770308.USD","LU2456880835.USD","IE00B775H168.HKD","LU0345770993.USD","LU1988902786.USD","LU0133085943.USD","LU0158827781.USD","LU2468319806.SGD","LU1868836757.USD","SG9999001176.USD","SG9999018865.SGD","BK4588","LU0456855351.SGD","LU0820562030.AUD","LU0964807845.USD","SG9999014898.SGD","LU0109394709.USD","SGXZ31699556.SGD","IE0009355771.USD","IE00BJLML261.HKD","LU1814569148.SGD","BK4007","LU0158827948.USD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU2028103732.USD","SG9999015945.SGD","LU2111349929.HKD","LU2750360997.AUD","LU2237443382.USD","LU2063271972.USD","SG9999014880.SGD","GB00BDT5M118.USD","LU1720051108.HKD","LU1804176565.USD","MHIP","LU0094547139.USD","LU2236285917.USD","LU2168563687.JPY","IE00BFSS7M15.SGD","LU2237443465.HKD","IE0002141913.USD","LU1093756168.USD","LU1623119135.USD","LU2462157665.USD","LU1145028129.USD","IE00B4R5TH58.HKD","LU2462591350.SGD","LU0432979614.USD","SGXZ81514606.USD","BK4581","THNR","LU2112291526.USD","IE00BWXC8680.SGD","LU0122379950.USD","LU1629891620.HKD","LU1093756325.SGD","LU1280957306.USD","LU0787776722.HKD","SG9999017495.SGD","IE0001KFT4U8.USD","LU2023250330.USD","LU2237443895.HKD","LU2271345857.HKD","LU2461242641.AUD","LU0097036916.USD","LU0234572021.USD","LU0323591593.USD","LU1127390331.HKD","LU0006306889.USD","LU2106854487.HKD","LU2360106947.USD","IE00BKDWB100.SGD","LU0058720904.USD","LU0320765059.SGD","LU0320765992.SGD","LLYX","LU0820561909.HKD","LU0471298777.SGD","LU0238689110.USD","LU2108987350.USD","LU1035775433.USD","LU0417517546.SGD","LU0820561818.USD","IHE","LU2089984988.USD","IE00BKPKM429.USD","LU0061475181.USD","LU2491050071.SGD","LU0943347566.SGD","LU1979441026.SGD","LU2471134796.USD","LU2264538146.SGD","IE00B7KXQ091.USD","LU0316494557.USD","BK4599","LU2168564222.USD","LLYZ","LU0353189680.USD","SGXZ57979304.SGD","LU1069344957.HKD","IYH","LU0466842654.USD","LU2552382058.USD","LU2471134952.CNY","PJP","MEDI","IE00BFTCPJ56.SGD","BK4533","WDNA","LLII","LU0471298694.HKD","LU2087625088.SGD","LU2023250504.SGD","LU2089284900.SGD","SG9999015986.USD","LU2211815571.USD","LU0114720955.EUR","SG9999001176.SGD","LU1917777945.USD","LU0225283273.USD","LU2361045086.USD","LU1868837136.USD","JDOC","BK4585","FHLC","LU0683600562.USD","XLV","LU1974910355.USD","LU0640476718.USD","ELIS","RXL","LU0198837287.USD","LU0823434740.USD","IE0004445239.USD","LU0823434583.USD","LU2213496289.HKD","LU2746668461.USD","LU1323610961.USD","SG9999014914.USD","IE00BJT1NW94.SGD","LU0354030511.USD","LU0823416689.USD","OZEM","PPH","SG9999015952.SGD","LU1712237335.SGD","LU0354030438.USD","LU1868837300.USD","TRUH","IE00B4JS1V06.HKD","LU2750360641.GBP","ELIL","LU1057294990.SGD","LU0289739699.SGD","LU1868836914.USD","SG9999013999.USD","LU0174119429.USD","LU2471134523.USD","LU1868836591.USD","IE0004445015.USD","IE00BJJMRY28.SGD","LU0266013472.USD","LU2602419157.SGD","SG9999014906.USD","IE00B1XK9C88.USD","LU2361044865.SGD","IE00BK4W5M84.HKD","LU0256863811.USD","IE0005OL40V9.USD","LU1061106388.HKD","LU2168564065.EUR","LU1064131342.USD","BK4534","FTXH","LU1232071149.USD","LU2237443622.USD","LU2168564495.EUR","LU1691799644.USD","SGXZ99366536.SGD","MEDX","LU1551013342.USD","LU1551013425.SGD","LU0385154629.USD","LU0106261372.USD","IE00BN29S564.USD","LU2023251221.USD","AGNG","CURE","LU1267930730.SGD","LU2896262040.SGD","LU1983299246.USD","LU0672654240.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217334","title":"Hims & Hers (HIMS) Stock Looks Like A Bargain After A 396% Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217334","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217334?lang=en_us&edition=fundamental","pubTime":"2026-08-23 09:23","pubTimestamp":1787448214,"startTime":"0","endTime":"0","summary":"Hims & Hers Health has delivered a very large 3 year gain for shareholders, yet the latest valuation work suggests the stock still trades at a discount to its estimated intrinsic value. With fresh headlines around AI in healthcare, peptide therapies and regulatory scrutiny, the big question for investors is how much of that story is already in the price.\n\nThe stock has returned about 396% over the past 3 years, which puts a lot of focus on whether the current share price can still be...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-hims-stock-looks-like-a-bargain-after-a-396-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-hims-stock-looks-like-a-bargain-after-a-396-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HEAL","HIMS","THNR","HMYY","HIYY","HIMY","HIMZ","GLAM","BK4196","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972218","title":"Market Chatter: Hims & Hers Health Faces Nearly $75,000 Bill From Card Disputes","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972218","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972218?lang=en_us&edition=fundamental","pubTime":"2026-08-22 06:27","pubTimestamp":1787351270,"startTime":"0","endTime":"0","summary":"Hims & Hers Health  was placed on notice by Visa for excessive customer complaints in its weight-loss subscription business, Bloomberg reported Friday, citing internal documents.The company was enrolled in Visa's Acquirer Monitoring Program after a surge in credit card disputes in July, with each dispute carrying an $8 surcharge that will result in a bill of nearly $75,000 in September, the report said, citing the documents.Hims was notified of its placement by payment processor Stripe earlier this month and must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program, according to the documents, Bloomberg reported.A Hims spokesperson said the company has seen \"a relatively small number of disputed charges\" and has taken steps to address it, adding that its checkout process is clear about membership and medication costs, the report said.Hims & Hers Health did not immediately respond to a request for comment from MT Newswires.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIMC","GLAM","HIYY","THNR","HEAL","HIMS","HMYY","HIMY","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661292181","title":"Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2661292181","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661292181?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:03","pubTimestamp":1787339001,"startTime":"0","endTime":"0","summary":"Scholar Rock's  latest update further de-risks the global apitegromab regulatory path, given the potential approval in the US and clear view on the Japan registration path, offsetting a delay in Europe, Wedbush said Friday.Earlier, Scholar Rock confirmed removal of Novo Nordisk's  Catalent Indiana as a commercial fill-finish facility from its US biologics license application, and it expects an approval decision from the US Food and Drug Administration by Sept. 30 for apitegromab as a treatment for spinal muscular atrophy.In Europe, Scholar Rock said it withdrew its marketing authorization application following the Catalent inspection issue and plans to resubmit with the new facility. In Japan, no additional clinical studies are needed, allowing a new drug application filing by year-end.Wedbush reiterated its outperform rating on Scholar Rock's stock and raised its price target to $64 from $58.Price: 56.16, Change: +0.91, Percent Change: +1.64","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRRK","BK4139","IBRN","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294877","title":"Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294877","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294877?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:45","pubTimestamp":1787330734,"startTime":"0","endTime":"0","summary":"Price: 56.19, Change: +0.94, Percent Change: +1.70","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBRN","SRRK","THNR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}